Ascendia Pharmaceutical Solutions

Exhibitors

Information

Ascendia Pharmaceutical Solutions is a specialty US CDMO providing custom formulation development and manufacturing. We deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Regarded As Safe) materials and 4 proprietary nanotechnologies - NanoSol, EmulSol, AmorSol and LipidSol. Following formulation selection and optimization, Ascendia can scale-up a development program quickly to cGMP manufacturing of clinical materials. Ascendia offers both aseptic and non-aseptic manufacturing for small molecules and biologics.

Exhibitor Type

Exhibitor

Organization Type

Manufacturer/InnovatorCMO/CDMO

Country

United States

Business Activity

Contract Manufacturer

Markets Active In

OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)

Products and Services

Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)

Service Categories

Analytical DevelopmentContract ManufacturingFormulation development

Company Certification

ISOGMP

Service Types

Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)